Analysts Set Expectations for Humana FY2025 Earnings

Humana Inc. (NYSE:HUM - Free Report) - Stock analysts at Cantor Fitzgerald issued their FY2025 EPS estimates for shares of Humana in a report released on Tuesday, January 21st. Cantor Fitzgerald analyst S. James anticipates that the insurance provider will earn $16.17 per share for the year. Cantor Fitzgerald has a "Neutral" rating and a $395.00 price target on the stock. The consensus estimate for Humana's current full-year earnings is $16.11 per share.

Humana (NYSE:HUM - Get Free Report) last posted its quarterly earnings results on Wednesday, October 30th. The insurance provider reported $4.16 earnings per share for the quarter, beating analysts' consensus estimates of $3.48 by $0.68. Humana had a return on equity of 13.20% and a net margin of 1.18%. The firm had revenue of $29.30 billion for the quarter, compared to the consensus estimate of $28.66 billion.

Other equities analysts have also recently issued reports about the company. Royal Bank of Canada reduced their price objective on Humana from $400.00 to $265.00 and set an "outperform" rating for the company in a report on Tuesday, October 8th. Deutsche Bank Aktiengesellschaft dropped their price target on shares of Humana from $349.00 to $250.00 and set a "hold" rating for the company in a research report on Thursday, October 3rd. TD Cowen lifted their price target on shares of Humana from $261.00 to $268.00 and gave the company a "hold" rating in a report on Monday, November 4th. Jefferies Financial Group lowered Humana from a "buy" rating to a "hold" rating and cut their target price for the stock from $519.00 to $253.00 in a research report on Monday, October 7th. Finally, Sanford C. Bernstein upgraded Humana from a "market perform" rating to an "outperform" rating and set a $308.00 price objective on the stock in a report on Tuesday, October 8th. Twenty research analysts have rated the stock with a hold rating and six have assigned a buy rating to the company's stock. According to MarketBeat.com, the company has an average rating of "Hold" and a consensus target price of $302.80.

Humana Price Performance

Shares of HUM stock traded up $8.30 during midday trading on Wednesday, reaching $293.22. 5,077,418 shares of the company traded hands, compared to its average volume of 1,584,673. The firm's 50 day simple moving average is $273.81 and its two-hundred day simple moving average is $305.88. The firm has a market cap of $35.31 billion, a PE ratio of 25.97, a price-to-earnings-growth ratio of 2.15 and a beta of 0.55. The company has a debt-to-equity ratio of 0.67, a current ratio of 1.76 and a quick ratio of 1.76. Humana has a 1-year low of $213.31 and a 1-year high of $411.80.

Insider Buying and Selling at Humana

In other Humana news, insider Timothy S. Huval sold 3,703 shares of the stock in a transaction that occurred on Tuesday, December 31st. The stock was sold at an average price of $256.26, for a total transaction of $948,930.78. Following the transaction, the insider now owns 8,181 shares of the company's stock, valued at $2,096,463.06. This trade represents a 31.16 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. 0.32% of the stock is currently owned by insiders.

Hedge Funds Weigh In On Humana

A number of hedge funds have recently added to or reduced their stakes in HUM. Marshall Wace LLP boosted its holdings in shares of Humana by 118.9% in the 2nd quarter. Marshall Wace LLP now owns 1,425,302 shares of the insurance provider's stock valued at $532,564,000 after buying an additional 774,085 shares during the period. International Assets Investment Management LLC boosted its stake in Humana by 261,025.1% in the third quarter. International Assets Investment Management LLC now owns 738,984 shares of the insurance provider's stock valued at $2,340,660,000 after acquiring an additional 738,701 shares during the period. FMR LLC grew its holdings in shares of Humana by 23.4% during the third quarter. FMR LLC now owns 3,388,859 shares of the insurance provider's stock valued at $1,073,387,000 after purchasing an additional 643,291 shares during the last quarter. Thrivent Financial for Lutherans raised its position in shares of Humana by 55.6% during the 3rd quarter. Thrivent Financial for Lutherans now owns 600,317 shares of the insurance provider's stock worth $190,145,000 after purchasing an additional 214,535 shares during the period. Finally, Pzena Investment Management LLC lifted its holdings in shares of Humana by 8.1% in the 3rd quarter. Pzena Investment Management LLC now owns 2,506,250 shares of the insurance provider's stock worth $793,830,000 after purchasing an additional 187,903 shares during the last quarter. Institutional investors and hedge funds own 92.38% of the company's stock.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.